Quartz Bio will offer highly specialized services to the pharmaceutical industry in the field of biomarker data analysis Merck Serono, a division of Merck, Darmstadt, Germany, announced today the ...
LAUSANNE, Switzerland -- Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs ...
The SIB Swiss Institute of Bioinformatics, Geneva Bioinformatics (GeneBio) SA and Quartz Bio SA today announced the establishment of a long-term collaboration under which they will cooperate in order ...
Merck Serono has spun out a bioinformatics firm, Quartz Bio, to provide biomarker data management and exploratory biomarker analysis services to the pharma industry. The new firm is the second created ...
Merck Serono, the biopharmaceutical division of Merck KGaA ( MKGAF), announced the creation of a new company, Asceneuron. Asceneuron is the third spin-off company of Merck Serono, apart from Prexton ...
Debiopharm Group™ has announced that they have signed a one-year collaboration agreement with Quartz Bio, the Clinical Bioinformatics Research Organization leader in precision biomarker discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results